Skip to main contentSkip to navigation
Sirius Investors
Johnson & Johnson

Johnson & Johnson

JNJ
NYSEHealthcare

Johnson & Johnson (JNJ) Investment Research Dashboard

About Johnson & Johnson (JNJ) stock analysis

Get live JNJ stock price $270.24, comprehensive Johnson & Johnson stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time JNJ stock data and investment insights.

270.24
1.07%Today
Market Cap
651.25B
Volume
6.18M
52W High
276.47
52W Low
173.33

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses o...

Company Information

CEO
Joaquin Duato
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
141700

Contact Information

Address
One Johnson & Johnson Plaza
Country
US

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - General

Investment Highlights

Market leader with 651.3 billion market capitalization

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 25.2)

Lower volatility stock (Beta: 0.23) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Johnson & Johnson shareholders
  • Market volatility can significantly impact stock price, especially for large-cap equities
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Johnson & Johnson
  • Investors should consider how Johnson & Johnson fits within their overall portfolio allocation

Market Cap

651.25B

P/E Ratio (TTM)

25.19

Beta

0.23

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

89/100 ⭐⭐⭐⭐⭐

Overall
+1.3%
NYSE
+1.6%
NASDAQ
+1.0%
Sector1D1W1MP/EScore
Healthcare+1.3%+4.3%+4.9%23.9
89/100⭐⭐⭐⭐⭐
Communication Services+0.4%-0.9%+5.4%19.1
85/100⭐⭐⭐⭐⭐
Consumer Defensive+0.5%+0.2%+3.2%28.4
72/100⭐⭐⭐⭐⭐
Energy-0.5%-1.0%+2.7%17.9
67/100⭐⭐⭐⭐
Financial Services+0.4%-1.8%+1.7%19.7
55/100⭐⭐⭐⭐
Consumer Cyclical+0.2%+1.0%+2.2%46.1
54/100⭐⭐⭐
Basic Materials+0.6%+0.1%-0.5%24.7
53/100⭐⭐⭐
Industrials+0.0%-2.3%-0.8%29.6
28/100⭐⭐
Technology-0.4%-2.2%-4.4%41.3
21/100
Real Estate-1.4%-2.5%-4.6%37.2
12/100
Utilities-2.3%-6.4%-14.7%24.4
12/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-08-23.